About Amgen JAPAC

Amgen's Japan Asia Pacific (JAPAC) is headquartered in Hong Kong. As a regional hub, the JAPAC office oversees Amgen's operations across the region. Amgen's JAPAC teams help to drive a shared ambition to bring innovative and high quality products to patients, and shape the healthcare environment in the region. Amgen's expansion in Asia comes at a time when the region's healthcare needs continue to grow, particularly around serious illnesses such as cancer, cardiovascular disease, bone and inflammation disease.

About Amgen Hong Kong/Macau

Amgen, one of the world's leading biotechnology companies, opened an affiliate office in Hong Kong in 2016, in order to make its innovative medicines available to patients in Hong Kong and Macau suffering from serious illnesses. Amgen’s entry into Hong Kong and Macau will bring more clinical trials and innovative therapies for grievous illnesses to local patients. Amgen also looks forward to being an active member of the local biotechnology community and helping to advance the growth of this industry in Hong Kong and Macau.